Skip to main content
. 2020 Apr 21;64(5):e02408-19. doi: 10.1128/AAC.02408-19

TABLE 5.

Imipenem-relebactam MICs among Escherichia coli isolates susceptible or nonsusceptible to comparator agents

Comparator agenta I-R MIC
P valueb
Susceptible to comparator agent
Nonsusceptible to comparator agent
MIC50 MIC90 Range Mean MIC50 MIC90 Range Mean
IPM 0.25 0.5 ≤0.03–1.0 0.27 0.25 32 0.06 to >256 19.3 ***
MEM 0.25 1.0 ≤0.03–2 0.35 0.5 64 0.12 to >256 43.1 ***
ETP 1.0 2 0.12–32 5.2 0.25 2 ≤0.03 to >256 11.1
GEN 0.25 1.0 ≤0.03 to >256 9.1 0.25 32 0.06 to >256 14.1
TZP 0.25 1.0 0.06–2 0.32 0.25 32 ≤0.03 to >256 15.0 *
AMK 0.25 1 ≤0.03 to >256 9.0 0.5 32 0.06 to >256 19.0 **
LVX 0.25 1 0.06–4 0.41 0.25 8 ≤0.03 to >256 14.0
TGC 0.25 2 ≤0.03 to >256 8.5 2 > 256 0.5 to >256 172 *
CAZ 0.5 2 0.125–2 0.59 0.25 4 0.25 to >256 12.0
CL 0.25 2 ≤0.03 to >256 11.0 0.5 0.50 0.125–0.5 0.31
MIN 0.25 1.0 0.06–64 2.0 0.25 64 ≤0.03 to >256 31.0 *
a

AMK, amikacin; CAZ, ceftazidime; CL, colistin; ETP, ertapenem; GEN, gentamicin; IPM, imipenem; I-R, imipenem-relebactam; LVX, levofloxacin; MEM, meropenem; MIN, minocycline; TGC, tigecycline; TZP, piperacillin-tazobactam.

b

P values as determined by Mann-Whitney test. *, P < 0.05; **, P < 0.01; ***, P ≤ 0.001.